Next Article in Journal / Special Issue
Miniaturized Bioaffinity Assessment Coupled to Mass Spectrometry for Guided Purification of Bioactives from Toad and Cone Snail
Previous Article in Journal
R-Based Software for the Integration of Pathway Data into Bioinformatic Algorithms
Biology 2014, 3(1), 101-138; doi:10.3390/biology3010101
Article

High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors

1
, 1
, 1,†
, 2
, 2
, 2
 and 1,*
Received: 7 January 2014; in revised form: 22 January 2014 / Accepted: 22 January 2014 / Published: 10 February 2014
(This article belongs to the Special Issue Screening for Biologically Active Compounds)
View Full-Text   |   Download PDF [1360 KB, uploaded 10 February 2014]   |   Browse Figures
Abstract: Hsp90 has become the target of intensive investigation, as inhibition of its function has the ability to simultaneously incapacitate proteins that function in pathways that represent the six hallmarks of cancer. While a number of Hsp90 inhibitors have made it into clinical trials, a number of short-comings have been noted, such that the search continues for novel Hsp90 inhibitors with superior pharmacological properties. To identify new potential Hsp90 inhibitors, we have utilized a high-throughput assay based on measuring Hsp90-dependent refolding of thermally denatured luciferase to screen natural compound libraries. Over 4,000 compounds were screen with over 100 hits. Data mining of the literature indicated that 51 compounds had physiological effects that Hsp90 inhibitors also exhibit, and/or the ability to downregulate the expression levels of Hsp90-dependent proteins. Of these 51 compounds, seven were previously characterized as Hsp90 inhibitors. Four compounds, anthothecol, garcinol, piplartine, and rottlerin, were further characterized, and the ability of these compounds to inhibit the refolding of luciferase, and reduce the rate of growth of MCF7 breast cancer cells, correlated with their ability to suppress the Hsp90-dependent maturation of the heme-regulated eIF2α kinase, and deplete cultured cells of Hsp90-dependent client proteins. Thus, this screen has identified an additional 44 compounds with known beneficial pharmacological properties, but with unknown mechanisms of action as possible new inhibitors of the Hsp90 chaperone machine.
Keywords: Hsp90; Hsp90 inhibitors; high-throughput screen; natural products libraries Hsp90; Hsp90 inhibitors; high-throughput screen; natural products libraries
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Davenport, J.; Balch, M.; Galam, L.; Girgis, A.; Hall, J.; Blagg, B.S.J.; Matts, R.L. High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors. Biology 2014, 3, 101-138.

AMA Style

Davenport J, Balch M, Galam L, Girgis A, Hall J, Blagg BSJ, Matts RL. High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors. Biology. 2014; 3(1):101-138.

Chicago/Turabian Style

Davenport, Jason; Balch, Maurie; Galam, Lakshmi; Girgis, Antwan; Hall, Jessica; Blagg, Brian S.J.; Matts, Robert L. 2014. "High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors." Biology 3, no. 1: 101-138.


Biology EISSN 2079-7737 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert